All posts by EPR Network

Biotech, Business, Financial, Healthcare, Religion, Science, Society

Advanced Cell Technology has pioneered a solution to the ethical, moral & legal debate raging in regards to protection of a human embryo

Leave a comment

May 10, 2011 /RTPR/– Advanced Cell Technology with laboratory facilities in Marlborough Massachusetts has pioneered a solution to the ethical, moral & legal debate raging in regards to protection of a human embryo. ACT has developed the “single-blastomere” technique. Patent Number 7,893,315 a non-destructive alternative for deriving human embryonic stem cell (hESC) lines.

This achievement in Regenerative medicine is a ground breaking feat for both Catholic and U.S. law.

• The 1995 encyclical The Gospel of Life, of which Pope John Paul II wrote: “Human embryos obtained in vitro are human beings and are subjects with rights; their dignity and right to life must be respected from the first moment of their existence. It is immoral to produce human embryos destined to be exploited as disposable ‘biological material'” (1,5 )
• The Dickey Amendment (also known as the Dickey-Wicker Amendment) is the name of an appropriation bill rider attached to a bill passed by United States Congress in 1995, and signed by former President Bill Clinton, which prohibits the Department of Health and Human Services (HHS) from using appropriated funds for the creation of human embryos for research purposes or for research in which human embryos are destroyed.

The single-blastomere technology uses a one-cell biopsy approach similar to pre-implantation genetic diagnosis (PGD), which is widely used in the in vitro fertilization (IVF) process and does not interfere with the embryo’s developmental potential. The stem cells generated using this approach are healthy, completely normal, and differentiate into all the cell types of the human The safety record for one-cell biopsy as part of PGD now has a 15-year track record, and is carried out routinely as part of IVF processes around the world. ACT’s technique of protecting the human embryo from harm can be expounded to the smallest blood transfusion in the world. As does a human being give millions of blood cells in a pint of blood so does ACT’s “single blastomere” process take but “one cell” from a 2 day old embryo. As the blood removed from a human donor “regenerate” the removed pint of blood so does the human embryo “regenerate” the one cell. Both of these procedures leave the human body & two day old embryo healthy. Both procedures are similar in that they both provide life saving material to those whom need them most to due to disease and other aliments of a medical nature.

Advanced Cell Technology has been granted by the US Food and Drug Administration (FDA) a Phase I/II multicenter clinical trial using retinal cells derived from human embryonic stem cells for both Stargardt’s Macular Dystrophy (SMD), one of the most common forms of juvenile macular degeneration in the world and Dry Age-Related Macular Degeneration (AMD) the most common form of macular degeneration in the world affecting an estimated 150 million people. ACT is using RPE cells developed from the patented (SCB) technique for this trial. The trial will take place at UCLA’s Jules Stein Eye Institute in California. Because of the biological nature of the human eye the trial will be able to provide a 100% irrefutable proof that the (hESC) derived RPE cells used attached to the Bruch’s membrane. Before and after state of the art imaging will take place.

Raymond Lund, Ph.D., a scientific collaborator with ACT, and considered one of the world’s foremost experts in retinal cell physiology and vision restoration, commented, “The study results of ACT’s RPE cells implanted in the various animal models of macular degeneration was phenomenal. If ACT observes even a fraction of that benefit in humans, it will be nothing short of a home run.”

FDA validation will occur for (hESC) medicine in less than 12 months. Will those that dictate law and morality to others lead? Will those suffering from disease all over the world finally have conclusive proof that (hESC) work? Life is filled with multifaceted choices and in a rare occurrence a quantum leap shows itself to the world. Human flight, computers and now regenerative medicine.

Disclosure: Stem Cell Media LLC nor its Companies was compensated by “any” entity for this article.www.investorstemcell.com is bringing investors and stakeholders together to participate in the world’s only online discussion forum dedicated to regenerative medicine.

Contact Details: icell@investorstemcell.com
www.investorstemcell.com

###

Biotech, Business, Financial, Healthcare, Pharmaceuticals, Science

NASDAQ:GERN & OTC:ACTC – A David & Goliath Comparison

Leave a comment

May 09, 2011 /RTPR/– Regenerative medicine is a highly complicated and vastly misunderstood science. Investor Stem Cell is dedicated to bringing investors and stakeholders together in thoughtful discussion to educate and publicize the incredible advancements unfolding in the regenerative medicine sector. A quantum leap in health care is upon the world. Will you profit from this emerging sector & help bring cures to millions? Find out now what the street thinks at www.investorstemcell.com.

Side by side comparison of Advanced Cell Technology & Geron Corporation:

Geron Corporation (NASDAQ:GERN), Approved by the FDA to use human embryonic stem cell (hESC) treatments to treat spinal cord injuries. The research Goliath is a well-funded machine employing the top minds in the world working on everything from mid-stage oncology trials to promising (hESC) drugs for spinal cord injuries, heart disease & cancer.

Snap shot of Goliath: Geron Corpoartion-(NASDAQ:GERN)-
• Seven oncology Phase 2 trials currently underway, and has several big Pharma joint venture agreements in oncology animal and human trials
• Five hESC areas of investigation underway. GRNOPC1 is the lead candidate. Geron destroys the human embryo through its (hESC) R&D, of which the company uses the blastocyst embryo formation at day five after fertilization from IVF clinics
• Cash, restricted cash, cash equivalents and marketable securities: $221,274.000.00
• Total operating expenses in 2010: $114,730,000.00
• 175 employees; over 100 hold PhD or MD degrees
• Geron Corporation was founded in 1990 and is based in Menlo Park, California
• Trades on the NASDAQ providing liquidity & large institutional investors
• Corporate financial statements:http://www.geron.com/investors/reports/GeronAnnualReport2010.pdf

Advanced Cell Technology not too long ago was the predominant leader in the field of regenerative medicine. It fell from that distinction in part due to executive management hubris and ultimately the credit crisis in mid-2008. ACT was able to resurrect itself from near bankruptcy in June 2008 and now has the distinction of holding two out of the three FDA approved (hESC) trials. ACT is led by a competent executive management team and employs several of the most predominant regenerative researcher(s) in the world.

Snap shot of David: Advanced Cell Technology-(OTC:ACTC)-
• Retinal Pigment Epithelial Cell Program is their lead program-(HESC) trials for both SMD/AMD are expected to start in week(s) Jules Stein Eye Institute at the University of California, Los Angeles (UCLA ) will conduct the 2 (hESC) trials for Stargardt’s Macular Dystrophy (SMD) and Dry Age-Related Macular Degeneration (AMD)
• Filed a European Clinical Trial Application for Phase 1/2 study using (hESC) to treat macular degeneration
• Issued a broad patent for hESC-derived RPE cells in China
• Seeking funding & joint venture partner for Myoblast program for the treatment of cardiovascular disease Phase 2 approved by the FDA
• Joint ventured with Korean medical giant CHA to form “Stem Cell & Regenerative Medicine International” (SCRMI). This partnership expected to file an investigational new drug application (IND) with the FDA in Q-4 of this year. CHA biotech is waiting for final approval from the Korea Food and Drug Administration for (hESC) trial for AMD
• Issued patent on its “single-blastomere” technique. Patent Number 7,893,315 broadly covers ACT’s proprietary single-blastomere technology that provides a non-destructive alternative for deriving hESC lines. This “Embryo-Safe” one-cell biopsy approach similar to pre-implantation genetic diagnosis (PGD), which is widely used in the in vitro fertilization (IVF) process and does not interfere with the embryo’s developmental potential
• 22 full-time employees, six hold PhD or MD degrees-Formed in 1994, HQ in Menlo Park, California with laboratory facilities in Marlborough, MA
• Total operating expenses in 2010: $22,044,701
• Cash, restricted cash, cash equivalents and marketable securities: $34,889,409
• Trades on the OTC:BB ACTC is a Sarbanes–Oxley Act SEC reporter
• Corporate financial statements:http://www.sec.gov/Archives/edgar/data/1140098/000101376211000631/form10k.htm

If you are looking for maximum possible ROI in the short term and can tolerate high risk, then maybe Advanced Cell Technology (OTC:ACTC) is for you? If ACT is validated by the FDA, the (RPE) MA-09 “embryo-safe” cell lines would open up an annual $25,000,000,000.00 market treating (AMD). Yes that is (b) with an (illion) annual market share! No FDA approved treatment exist for (AMD) in the world. This disease effects 30 million in the USA & EU alone. Cell lines have potential to treat 200 retinal eye diseases. ACT has been approved for U.S. Orphan Drug status protection for (SMD). This status by the FDA provides ACT seven years of market protection. ACT is expecting EU-Orphan Drug status for (SMD) and if awarded would receive 10-years of market protection. The recent patent protection for ACT’s RPE cells in China firmly establish potential world dominance of the (AMD) market. What is the down side? One glaring red flag is that ACT has two years of operating capital and enough cash to fund both the SMD/AMD Phase-1/2 trials in the U.S. If ACT’s AMD/SMD trials are not validated, ACT would most likely be forced to institute a massive reverse split due to the O/S nearing its A/S. ACT has placed all of its eggs in one pipeline basket, choosing the low hanging fruit model. ACT is counting on the exceptional Casey Eye Clinic animal results. Dr. Raymond Lund Ph.D., considered one of the world’s foremost experts in retinal cell physiology and vision restoration. Dr. Lund recently said the following: “The study results of ACT’s RPE cells implanted in the various animal models of macular degeneration was phenomenal. If ACT observes even a fraction of that benefit in humans, it will be nothing short of a home run.”

Disclosure: www.investorstemcell.com is the world’s only online discussion forum dedicated bringing investors & stakeholders together in thoughtful discussion about stem cell & regenerative medicine. www.investorstemcell.com nor any of its Companies have been compensated by “any” party for this article. Before making an investment decision an investor should perform due diligences. Once completed find out what the street thinks at www.investorstemcell.com

Contact Details: www.investorstemcell.com
icell@investorstemcell.com

###

Automotive, Marketing, Transportation & Logistics

RPM Auto Sales USA Has Grown Into One Of The Largest Used Car And Truck Dealers In Ocean County

Leave a comment

May 07, 2011 /RTPR/ — RPM Auto Sales USA located at 980 Route 9 in Bayville has grown it’s business into one of the largest used car and truck dealers in Ocean County by exceeding their customer’s expectations. RPM only inventories the highest quality of used cars and trucks so that customers who visit the Rpm 6 acre facility want to buy their vehicles hence, there is never any pressure to buy from their friendly staff.

RPM Autos has used vehicle buyers that have over 100 years of used car experience that purchase clean vehicles for RPM’s customers with clean
Carfaxes. Rpm has finance reps on location to get all loans approved for their clients on the spot with rates as low as 3.9%. Please call Rpm Auto Sales Usa at 800.622.7079 for more info or visit their website at www.rpmautosalesusa.com.

RPM Auto Sales…Your Friends in The Business!

Contact Details: RPM Auto Sales Usa
980 RT 9
Bayville, NJ, 08721
800.622.7079 www.rpmautosalesusa.com

###

Accounting, Financial, Government, Internet & Online, Non-Profit, Society

New Report Describes Poor Quality Tax Preparation In New Mexico

Leave a comment

LONGMONT, Colorado (May 6, 2011) – Between February 1 and April 18, 2011, First Nations Development Institute conducted 12 “mystery shopper” tests of paid tax preparers in New Mexico. These mystery shopper tests were conducted in communities with a high Native American population and close to Indian reservations. First Nations visited tax preparer sites in Gallup, Grants, Bernalillo, Farmington, and Albuquerque, New Mexico. The goal of the work was to assess the quality of tax preparation services and to test the hypothesis that the tax preparation firms are steering people toward expensive products, such as Refund Anticipation Loans or Refund Anticipation Checks.

This research uncovered several problems with inaccurate, unethical, or unprofessional behavior on the part of tax preparers. “In our small sample of mystery shoppers, it was shocking what we uncovered,” stated Shawn Spruce, a financial education consultant for First Nations. Spruce also shared,“Unfortunately, the companies that our mystery shoppers visited did a poor job preparing even basic tax returns and could have exposed them to serious tax liability. In general, we were startled by the low quality service and the fact that two of these companies automatically signed our shoppers up for expensive Refund Anticipation Checks, even though they could have directly deposited their tax returns into their own bank accounts.”

Michael E. Roberts, president of First Nations Development Institute, stressed the importance of conducting the mystery shopper tests and resulting research on tax preparers.

“This research reinforces what other studies have found,” stated Roberts. “There is a great need for better regulation of tax preparers so that low-income people can hold on to their hard earned tax refunds and avoid expensive and predatory products like Refund Anticipation Checks. It is unfortunate that tax time serves as an opportunity to exploit Native American taxpayers through high fees and unnecessary products that take money out of taxpayers’ pockets.”

On May 4, 2011, Spruce presented the findings in Tax Time Troubles, a First Nations Development Institute report that provides details about predatory, unprofessional, and inaccurate tax preparation firms serving often low income communities in New Mexico. Spruce was the evening keynote speaker at the Effective Asset Building Strategies in New Mexico conference being held at the Indian Pueblo Cultural Center in Albuquerque, New Mexico. This conference was sponsored by Prosperity Works, a nonprofit organization that works to reduce the impact of predatory lending and whose mission is to ensure that every New Mexican has the opportunity, knowledge and relationships to achieve economic prosperity.

For more information about the research report Tax Time Troubles, visit First Nations Development Institute’s website at www.firstnations.org.

###

CONTACT:
Sarah Dewees, Senior Director of Research, Policy, and Asset-Building Programs
First Nations Development Institute
2217 Princess Anne Street, Suite 111-1
Fredericksburg, VA 22401
Tel/540.371.5615
Fax/888.371.3686
sdewees@firstnations.org

###

Consumer Services, Entertainment, Internet & Online, Kids & Teens, Media, Social Media, Society

BabyFirstTV.com Turns 5 Years This Mother’s Day

Leave a comment

LOS ANGELES (May 5, 2011) – Mother’s Day marks the 5 th birthday of BabyFirstTV, the global TV network designed for babies and parents. Since its launch in 2006, the network has grown to become a multi-platform media company with family-friendly content extending beyond the TV to mobile devices and the internet.

BabyFirstTV.com, the latest product stemming from the media company, is a colorful, interactive website that combines over 400 videos, games and activities all designed specifically for toddlers. Created by early childhood development experts, the website is commercial-free and full of fun ways for parents and children to interact together – online. Families around the world can use BabyFirstTV.com completely for free this Mother’s Day weekend, May 6-9.

“Our fifth anniversary, is a great opportunity to thank the millions of moms and dads around the globes, that have followed us, and have become part of the BabyFirst family,” said co-founder, Sharon Rechter.

“To celebrate the unique bond between children and their parents, we have made the BabyFirstTV.com subscription service free for parents and toddlers to play, explore and discover together.”

Outside the Mother’s Day free trial weekend, BabyFirstTV.com is available as a subscription-based service for $3.99 a month or an annual fee of $19.99 (which includes two free BabyFirstTV DVDs). Existing BabyFirstTV channel subscribers pay only $1.99 per month.

About BabyFirstTV:

BabyFirstTV is a commercial–free, 24/7 network for young children and their parents.  Working closely with an extensive network of renowned authorities in every area of early childhood psychology and education, BabyFirstTV is a trusted, age-appropriate network throughout the world. BabyFirstTV is currently available to more than 50 million households in 35 countries including the top five U.S. satellite and cable operators. BabyFirstTV is included in the basic package on Dish Network and available as a premium service via DIRECTV, Time-Warner, Comcast and Charter. BabyFirstTV is committed to creating a commercial-free, nurturing and interactive environment by offering an ever-changing lineup of quality content.  For more info: www.babyfirsttv.com.

###

Biotech, Financial, Healthcare, Pharmaceuticals, Science

Investor Stem Cell Launches Online Discussion Community Dedicated To Stem Cell Investors

Leave a comment

APR 29, 2011 /RTPR/ — Investor Stem Cell (http://www.investorstemcell.com) is dedicated to bringing investors and stakeholders together in thoughtful discussion to educate and publicize the incredible medical advancements taking place in the regenerative medicine sector. Scientists are using stem cells both (hESC) and (iPSC) in hopes of easing the suffering of hundreds of millions of people world wide.

Our society is on the verge of a quantum leap moment in time thanks to regenerative medicine.

Regenerative medicine and Stem Cell research:

Utter those words at your next dinner party or casual gathering of friends and family. You will receive a concoction of half-truth’s and out right fallacy responses. Stem Cell research conjures images of futuristic Star–Trek like preservation chambers, human looking ears protruding oddly from the backs of mice, or worse yet an image of a late term fetus. Nothing could be farther from the truth when entering the reality of Regenerative medicine.

Never before has this area of research been more exciting and promising than right now. There is a medical revolution brewing, and like any revolution, there are those who want to suppress this uprising for continued personal and ideological gains. If we were to take all the major advances in the past 500 years of human medical history and multiply its effect by 10 fold it still would not compare to the paradigm shift in health care delivery that the world may witness in this decade using stem cells. Imagine that an $800,000 heart transplant is no longer needed and that instead the same money spent on one patient can now be stretched out to treat 20 patients who are needing a heart transplant. Is this what Regenerative medicine has in the offing? Only time will tell. Our healthcare system could very well be on the verge of a quantum leap moment thanks to regenerative medicine.

The Food and Drug Administration (FDA) authorized 3 trials using human embryonic stem cells (hESC) in late 2010. Validation of hESC research efforts and the culmination of billions spent on research are coming to fruition. FDA validation for the treatments of spinal cord injury and age related macular degeneration is expected in 2011. It may be the shot heard around the world event sometime in late Q-4 2011 for the Regenerative medicine sector.

Find out more at http://www.investorstemcell.com, where investing is much more than charts and numbers.

Investor Stem Cell offers dedicated forums to the following Stem Cell Companies.
Investor Stem Cell is free to all members and employs the state of the art discussion web based software to maximize the experience of its members and the user experience. Get involved now and start separating fact from fiction in Regeneration medicine.

Investor Stem Cell provides Forums for the below Stem Cell Companies.

Advanced Cell Technology (OTC:ACTC) Geron Corporation (NASDAQ:GERN)

Cord Blood America (Public, OTC:CBAI) BioTime (AMEX:BTX)

Aastrom Biosciences (NASDAQ:ASTM) Athersys Inc. (NASDAQ:ATHX)

International Stem Cell Corporation (OTC:ISCO) MultiCell (OTC:MCET)

StemCells, Inc. (NASDAQ:STEM) Thermogenesis (NASDAQ:KOOL)

Bioheart Inc. (OTC:BHRT) RTI Biologics (NASDAQ:RTIX)

Pluristem Therapeutics Inc. (NASDAQ:PSTI) Bio-Matrix Scientific Group (PINK:BMSN)

Neuralstem (AMEX:NBS) Opexa Therapeutics (NASDAQ:OPXA)

Stem Cell Authority (PINK:SCLL) Brainstorm Cell Therapeutics (OTC:BCLI)

Stem Cell Therapeuitics (CVE:SSS) Cyro-Cell International (OTC:CCEL)

CellCyte Genetics(OTC:CCYG) Stem Cell Innovations (PINK:SCLL)

BioMimetic Therapeutics (NASDAQ:BMTI) Mesoblast (ASX:MSB)

Cytori Therapeutics (NASDAQ:CYTX) SANUWAVE Health, Inc. (OTC:SNWV)

Disclosure: By being a visitor and or member of Investor Stem Cell you agree to adhere to the Terms of Service at all times & pay strict attention to (TOS) Stem Cell Media LLC – http://www.investorstemcell.com is not paid by any 3rd party now or in the future to promote “any” companies for credibility and ethical reasons. Investors Stem Cell is not a financial advisory service. Consult your financial advisor at all times before making an investment. Our society is on the verge of a quantum leap moment in time thanks to regenerative medicine.

Contact Details: www.investorstemcell.com
email = icell@investorstemcell.com

###

Art, Entertainment, Marketing, Media, Music

Chicago based artist Narisah Announces New Single Release

Leave a comment

Narisah jokes that she’s a German pop / Ghettotech artist because she says her music is art and belongs to no particular genre. Narisah a Chicago based artist is set to unveil her new single ‘Crash Dummy’ on April 29th, 2011.

The track comes from the forthcoming studio album ‘Crash Dummy’ which consequently has a revised release date of early July 2011. She’s working with her long time producer Ic.ON from Chicago on the project.

‘Crash Dummy’, which will be available in Digital format only, will be the first single released off of the Crash Dummy EP due out in early July of 2011. It follows previous singles ‘E.S.P’ the theme song from the movie E.S.P and ‘Money’ from the sound track of ‘E.S.P’ the movie.

‘Crash dummy’ the single will be available for a free download. The music video is approaching too.

‘Crash Dummy’ the EP will be released in early July 2011.

For more information and to download the new single visit:
http://www.reverbnation.com/narisah
www.myspace.com/NerissaRahKelly
http://www.narisah.com/

Contact Details: Shannon Lechner
707 E Mulberry #2
Chatham, IL815-302-1422

###

Art, Construction, Home & Garden, Marketing, Media, Real Estate, Retail, Shopping

Ligne Roset Sponsors the Wanted Design NYC

Leave a comment

APR 28, 2011 /RTPR/ — Ligne Roset is proud to announce its sponsorship of the Wanted Design NYC, a fresh and exciting addition to Design Week, held in New York City. This creative platform for international designers, architects, and manufacturers to discuss and share exciting, inspiring and innovative ideas will take place from May 13 through May 16.

Ligne Roset will be honored by the presence of Philippe Nigro, who will present some of his pieces introduced earlier this year at IMM and Maison et Objet.

Creations designed by Philippe Nigro include Inseparables and T.U., and some of the new pieces making their debut Stateside will be Passio, Cuts and Stripes. Inseparable is a multifunctional piece which can act as a sofa end table, seat or simply a foot rest. The table can be slotted into the footstool or kept separately. The T.U. table also demonstrates a versatile quality as it has reversible top panels which can be flipped to show different materials and colors or can be altered in terms of width and height to suit the room or occasion. The sofa Passio is the introduction to our new outdoor collection. Its inventive design was conceived for indoor living, but the choice of materials allows it to be enjoyed outdoors. Nigro’s signature themes of intersections and interlocking elements are apparent in the arms and back. His passion for repetition and variation continues with the bookcase Cuts and with the pendant lamp Stripes.

In conjunction with Wanted Design, Ligne Roset’s Soho showroom will decorate its window with Ploum, one of the most exciting pieces to come out of IMM Cologne 2011. Designed by Ronan & Erwan Bouroullec, this will mark the first time Ploum will be seen in North America.

Inga Sempé,

Ligne Roset is also proud to congratulate designer Inga Sempé, who was recently recognized at the 9 th Annual Elle Decoration International Design Awards (EDIDA). She won the Seating Category with her Ruché sofa and was also named Designer of the Year. This innovative sofa gets its name from the technique of gathering or pleating material and has a solid wood structure.

Ligne Roset

Ligne Roset is an international contemporary furnishings company with a high-end, design-forward line of upholstery, cabinetry, lighting, accessories and textiles geared toward the modern lifestyle. Recent introductions include artful collaborations with world’s most dynamic designers such as Inga Sempé, Ronan & Erwan Bouroullec and Philippe Nigro, as well as pieces by established talents such as Didier Gomez and Pascal Mourgue. For Wanted Design, Ligne Roset is excited to highlight pieces by renowned young designer Philippe Nigro.

For more information about Ligne Roset, please visit the website http://www.ligne-roset-usa.com or for readers in the UK please visit http://www.ligne-roset.co.uk/. If you’re interested in learning more about the event, please check out their website www.wanteddesignnyc.com.

###

Apparel & Fashion, Internet & Online, Retail, Shopping

Extremepie.com: Latest Vans Styles Offer Universal Appeal

Leave a comment

APR 22 2011 /RTPR/– The original skate shoes manufacturer proves to be a big hit with the youth market at Extremepie.com; however the highly functional and stylish skate have much broader appeal.

Vans shoes first came to the market in 1966, catering to the growing popularity of skateboarding and rapidly became one of the best loved street brands, producing a wide range of shoes and apparel specifically targeting the highly popular sport. With such a long pedigree in the industry, it is no surprise that they are one of the leading brands for skaters, and with top names endorsing the brand including some of the world’s leading skateboarders, and sponsorship of some of the major skating and x-games events, they remain at the forefront of the sport.

“Vans are one of the most easily recognisable skate brands, having provided the footwear for generations of skaters since the birth of the sport in the 1960’s and are just as popular today as when the skating craze first started” says Extremepie.com MD Richard Gundle. The shoes are a popular choice at the online skating and extreme sports apparel store, with the brand no longer restricted to skaters, with it now catering to the full range of street sports.

Whilst the brand has diversified from skater apparel and footwear into all extreme street sports, Vans shoes are still primarily constructed for skateboarders, providing a high quality construction, double and triple stitched panels for extra protection from grip tape, and use leather and mesh for comfort and breathability, in addition to traditional suede to give greater durability to deal with a highly abrasive environment.

Vans shoes are the product of years of research and testing, and feature the waffle grip sole unit which is still widely regarded as the best sole design for skate shoes in the industry, providing unbeatable grip and great board feel. Vans shoes use vulcanized sticky rubber for the soles, with a waffle iron pattern to maximise surface area for expert traction, whilst each section acting as a sucker to keep the feet firmly on the board. Skate shoes are known to have to deal with brutal treatment, with Vans shoes designed to cope with the abuse from grip tape and concrete, with high wear areas reinforced to improve the lifespan. Vans have incorporated their Duracap system into the shoes, so that they remain functional when the uppers wear through, thanks to a thin rubber underlay which prolongs the lifespan considerably.

There is a trade off between feel and robustness in skate shoes; however Vans shoes achieve a good balance, being some of the most lightweight skate shoes on the market which has helped to build their appeal. An Extralite construction keeps the weight down to the bare minimum, whilst offering high impact shock protection to cope with drop ins and heavy landings, with a TPU heel cap to provide extra rigidity and stability to prevent ankle roll on sketchy landings, whilst not adding much to the weight.

The brand is a firm favourite with skaters and BMXers for the technical performance; however the brand is being increasingly chosen for its highly fashionable street styling, which appeals not just to the youth market but for anyone who grew up in the glory days of skateboarding. “The latest Vans shoes styles have been a bit hit at Extremepie.com since their introduction, and with such a wide range of colourful and fashionable styles they are a popular choice not just with skaters, but in the mainstream fashion market too” says Richard, with the claims backed up by strong first quarter sales at the online store.

For further information on Vans shoes visit http://www.extremepie.com

Contact Details: Luke Barlow
0844 871 2920
Extreme Innovations Ltd
Unit 3 Rignals Lane
Galleywood,
Chelmsford,
Essex.CM2 8RF

###

Apparel & Fashion, Internet & Online, Retail, Shopping, Sports

Surge in Sales of Keen Shoes

Leave a comment

APR 22 2011 /RTPR/– Warm spring weather sparks a surge in sales of Keen Shoes, as water sports and outdoor enthusiasts are able to secure early season discounts on hybrid shoes for the summer.

The first decent spell of warm sunny spring weather is usually enough to see consumers heading to the shops and online stores to pick up new footwear for the summer. This year has proved to be no different, with most of the country bathed in sunshine and temperatures heading into the twenties, it was a welcome reminder that summer is fast approaching and that wardrobes need to be replenished before the summer starts. Visitors to online performance footwear retailer Fitnessfootwear.com have been treated to massive early season discounts on summer shoes and sandals, with Keen shoes one of the most popular choices. Current discounts offer up to 20% savings on the recommended retail price, something which has proved to be too much to resist for its customers with Keen shoes sales soaring.

Keen shoes started life in 2003, with the brand formed with the singular goal of producing a new breed of sandal which offered exceptional protection for the toes. The brand was launched with the Keen Newport, a revolutionary new shoe with the lightweight and airy design of a sandal and the sturdy performance of a walking shoe. Termed hybrid footwear, the shoes offered the benefits of both shoes and sandals, and proved to be an instant hit with outdoor enthusiasts, with both hikers and water sports aficionados flocking to the brand. One of the key components which made the brand such a runaway success is the patented toe protection system. The soles of Keen shoes wrap up and around the toes for exceptional protection on the trail and from underwater hazards, with the quick drying water resistant design ideal for a life in and out of the water. Whilst the toe protection system was designed for use in their range of sandals, the system now features in every Keen shoe model, even in their range of slippers, making stubbed toes a thing of the past.

In addition to the technology used in their toe protection system, Keen has developed a host of new technologies to further enhance comfort and performance, with the brand developing a reputation for innovation throughout its footwear range. Keen shoes offer an excellent fit thanks to the metanomical footbed, which closely follows the contours of the foot for excellent support and day long comfort, whilst the footbed takes on the shape of the individual’s foot for an exceptionally comfortable and personal fit. With the comfort, performance, protection and versatility of Keen shoes it is no surprise that they are such a popular choice.

The Keen shoes collection at Fitnessfootwear.com has long been a firm favourite with its customers; with the brand selling exceptionally well from the late spring through to the autumn. “Keen shoes are once again topping the sales charts now that the weather is improving, with the full range selling well” says Fitnessfootwear.com MD Richard Gundle. The heavy discounts were put in place to encourage early season purchases; and with the run of warm weather boosting visitors to the website, the tactic appears to have worked, with sales of Keen shoes soaring as customers have found the innovative hybrid footwear difficult to resist.

Further information on the Keen shoes collection can be found at http://www.fitnessfootwear.com with a quick purchase recommended to enjoy the current heavily discounted rates

Contact Details: Luke Barlow,
0844 815 0600
Unit 3 Rignals Lane
Galleywood,
Chelmsford,
Essex.CM2 8RF

###